Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
8
SKIN Quote, Financials, Valuation and Earnings
Last price:
$1.00
Seasonality move
:
-11.09%
Day range:
$0.97 - $1.16
52-week range:
$0.91 - $3.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.45x
P/B ratio:
2.61x
Volume:
2.1M
Avg. volume:
837.6K
1-year change:
-71.95%
Market cap:
$135.3M
Revenue:
$334.3M
EPS (TTM):
-$0.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKIN
The Beauty Health
|
$63.9M | -$0.07 | -21.04% | -30% | $1.58 |
|
EWCZ
European Wax Center
|
$49.7M | $0.05 | -3.47% | -6.25% | $6.31 |
|
GROV
Grove Collaborative Holdings
|
$47M | -$0.04 | -12.21% | -60% | $2.50 |
|
HIMS
Hims & Hers Health
|
$535.2M | $0.21 | 92.4% | 312.9% | $44.16 |
|
KVUE
Kenvue
|
$3.7B | $0.23 | -5.39% | 54.63% | $24.25 |
|
SNBH
Sentient Brands Holdings
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKIN
The Beauty Health
|
$1.08 | $1.58 | $135.3M | -- | $0.00 | 0% | 0.45x |
|
EWCZ
European Wax Center
|
$3.84 | $6.31 | $166.4M | 17.15x | $0.00 | 0% | 0.83x |
|
GROV
Grove Collaborative Holdings
|
$1.15 | $2.50 | $46.2M | -- | $0.00 | 0% | 0.21x |
|
HIMS
Hims & Hers Health
|
$29.49 | $44.16 | $6.6B | 54.61x | $0.00 | 0% | 4.73x |
|
KVUE
Kenvue
|
$21.78 | $24.25 | $41.6B | 41.09x | $0.21 | 3.74% | 2.71x |
|
SNBH
Sentient Brands Holdings
|
$0.07 | -- | $4.8M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKIN
The Beauty Health
|
91.42% | -0.496 | 278% | 5.85x |
|
EWCZ
European Wax Center
|
85.49% | 0.533 | 115.69% | 1.58x |
|
GROV
Grove Collaborative Holdings
|
31.62% | 2.293 | 9.37% | 0.73x |
|
HIMS
Hims & Hers Health
|
-- | 7.394 | -- | 1.38x |
|
KVUE
Kenvue
|
46.77% | 0.931 | 20.79% | 0.65x |
|
SNBH
Sentient Brands Holdings
|
-- | -1.884 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKIN
The Beauty Health
|
$52.3M | -$7.2M | -4.33% | -47.95% | -11.09% | $15.6M |
|
EWCZ
European Wax Center
|
$37M | $12.8M | 2.18% | 9.76% | 16.01% | $16.3M |
|
GROV
Grove Collaborative Holdings
|
$25.9M | -$8.3M | -39.61% | -154.22% | -22.3% | -$95K |
|
HIMS
Hims & Hers Health
|
$369.5M | $18.6M | 32.03% | 32.03% | 3.87% | $59.5M |
|
KVUE
Kenvue
|
$2.1B | $557M | 5.43% | 9.84% | 13.49% | $661M |
|
SNBH
Sentient Brands Holdings
|
-- | -$78.3K | -- | -- | -- | -$200 |
The Beauty Health vs. Competitors
-
Which has Higher Returns SKIN or EWCZ?
European Wax Center has a net margin of -12.37% compared to The Beauty Health's net margin of 3.96%. The Beauty Health's return on equity of -47.95% beat European Wax Center's return on equity of 9.76%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health62.69% -$0.08 $604M EWCZEuropean Wax Center74.34% $0.04 $468.8M -
What do Analysts Say About SKIN or EWCZ?
The Beauty Health has a consensus price target of $1.58, signalling upside risk potential of 45.83%. On the other hand European Wax Center has an analysts' consensus of $6.31 which suggests that it could grow by 64.39%. Given that European Wax Center has higher upside potential than The Beauty Health, analysts believe European Wax Center is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health0 7 0 EWCZEuropean Wax Center3 5 1 -
Is SKIN or EWCZ More Risky?
The Beauty Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or EWCZ?
The Beauty Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKIN or EWCZ?
The Beauty Health quarterly revenues are $83.5M, which are larger than European Wax Center quarterly revenues of $49.7M. The Beauty Health's net income of -$10.3M is lower than European Wax Center's net income of $2M. Notably, The Beauty Health's price-to-earnings ratio is -- while European Wax Center's PE ratio is 17.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health is 0.45x versus 0.83x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health0.45x -- $83.5M -$10.3M EWCZEuropean Wax Center0.83x 17.15x $49.7M $2M
-
Which has Higher Returns SKIN or GROV?
Grove Collaborative Holdings has a net margin of -12.37% compared to The Beauty Health's net margin of -25.53%. The Beauty Health's return on equity of -47.95% beat Grove Collaborative Holdings's return on equity of -154.22%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health62.69% -$0.08 $604M GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M -
What do Analysts Say About SKIN or GROV?
The Beauty Health has a consensus price target of $1.58, signalling upside risk potential of 45.83%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.50 which suggests that it could grow by 117.39%. Given that Grove Collaborative Holdings has higher upside potential than The Beauty Health, analysts believe Grove Collaborative Holdings is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health0 7 0 GROVGrove Collaborative Holdings2 0 0 -
Is SKIN or GROV More Risky?
The Beauty Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or GROV?
The Beauty Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or GROV?
The Beauty Health quarterly revenues are $83.5M, which are larger than Grove Collaborative Holdings quarterly revenues of $49.5M. The Beauty Health's net income of -$10.3M is higher than Grove Collaborative Holdings's net income of -$12.6M. Notably, The Beauty Health's price-to-earnings ratio is -- while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health is 0.45x versus 0.21x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health0.45x -- $83.5M -$10.3M GROVGrove Collaborative Holdings0.21x -- $49.5M -$12.6M
-
Which has Higher Returns SKIN or HIMS?
Hims & Hers Health has a net margin of -12.37% compared to The Beauty Health's net margin of 5.41%. The Beauty Health's return on equity of -47.95% beat Hims & Hers Health's return on equity of 32.03%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health62.69% -$0.08 $604M HIMSHims & Hers Health76.81% $0.11 $476.7M -
What do Analysts Say About SKIN or HIMS?
The Beauty Health has a consensus price target of $1.58, signalling upside risk potential of 45.83%. On the other hand Hims & Hers Health has an analysts' consensus of $44.16 which suggests that it could grow by 49.75%. Given that Hims & Hers Health has higher upside potential than The Beauty Health, analysts believe Hims & Hers Health is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health0 7 0 HIMSHims & Hers Health4 7 1 -
Is SKIN or HIMS More Risky?
The Beauty Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.654, suggesting its more volatile than the S&P 500 by 65.449%.
-
Which is a Better Dividend Stock SKIN or HIMS?
The Beauty Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or HIMS?
The Beauty Health quarterly revenues are $83.5M, which are smaller than Hims & Hers Health quarterly revenues of $481.1M. The Beauty Health's net income of -$10.3M is lower than Hims & Hers Health's net income of $26M. Notably, The Beauty Health's price-to-earnings ratio is -- while Hims & Hers Health's PE ratio is 54.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health is 0.45x versus 4.73x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health0.45x -- $83.5M -$10.3M HIMSHims & Hers Health4.73x 54.61x $481.1M $26M
-
Which has Higher Returns SKIN or KVUE?
Kenvue has a net margin of -12.37% compared to The Beauty Health's net margin of 8%. The Beauty Health's return on equity of -47.95% beat Kenvue's return on equity of 9.84%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health62.69% -$0.08 $604M KVUEKenvue56.53% $0.15 $18.2B -
What do Analysts Say About SKIN or KVUE?
The Beauty Health has a consensus price target of $1.58, signalling upside risk potential of 45.83%. On the other hand Kenvue has an analysts' consensus of $24.25 which suggests that it could grow by 11.36%. Given that The Beauty Health has higher upside potential than Kenvue, analysts believe The Beauty Health is more attractive than Kenvue.
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health0 7 0 KVUEKenvue3 13 0 -
Is SKIN or KVUE More Risky?
The Beauty Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or KVUE?
The Beauty Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.74% to investors and pays a quarterly dividend of $0.21 per share. The Beauty Health pays -- of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or KVUE?
The Beauty Health quarterly revenues are $83.5M, which are smaller than Kenvue quarterly revenues of $3.7B. The Beauty Health's net income of -$10.3M is lower than Kenvue's net income of $293M. Notably, The Beauty Health's price-to-earnings ratio is -- while Kenvue's PE ratio is 41.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health is 0.45x versus 2.71x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health0.45x -- $83.5M -$10.3M KVUEKenvue2.71x 41.09x $3.7B $293M
-
Which has Higher Returns SKIN or SNBH?
Sentient Brands Holdings has a net margin of -12.37% compared to The Beauty Health's net margin of --. The Beauty Health's return on equity of -47.95% beat Sentient Brands Holdings's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health62.69% -$0.08 $604M SNBHSentient Brands Holdings-- -$0.01 -- -
What do Analysts Say About SKIN or SNBH?
The Beauty Health has a consensus price target of $1.58, signalling upside risk potential of 45.83%. On the other hand Sentient Brands Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that The Beauty Health has higher upside potential than Sentient Brands Holdings, analysts believe The Beauty Health is more attractive than Sentient Brands Holdings.
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health0 7 0 SNBHSentient Brands Holdings0 0 0 -
Is SKIN or SNBH More Risky?
The Beauty Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sentient Brands Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or SNBH?
The Beauty Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sentient Brands Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health pays -- of its earnings as a dividend. Sentient Brands Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or SNBH?
The Beauty Health quarterly revenues are $83.5M, which are larger than Sentient Brands Holdings quarterly revenues of --. The Beauty Health's net income of -$10.3M is lower than Sentient Brands Holdings's net income of -$291.8K. Notably, The Beauty Health's price-to-earnings ratio is -- while Sentient Brands Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health is 0.45x versus -- for Sentient Brands Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health0.45x -- $83.5M -$10.3M SNBHSentient Brands Holdings-- -- -- -$291.8K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.
Sell
31
TECS alert for Apr 10
Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.
